Ex vivo generation of human alloantigen-specific regulatory T cells from CD4posCD25high T cells for immunotherapy

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Peters, Jorieke H ^a   Hilbrands, Luuk B ^a   Koenen, Hans J P M ^a   Joosten, Irma ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD3 ANTIBODY; CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL ISOLATION; CONTROLLED STUDY; EX VIVO STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; POLYCLONAL ACTIVATION; REGULATORY T LYMPHOCYTE; CLONAL ANERGY; FLOW CYTOMETRY; IMMUNOLOGY;

ANIMALIA;

ANTIGENS, CD4; CLONAL ANERGY; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; T-LYMPHOCYTES, REGULATORY;

EID: 48249098901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002233     Document Type: Article

References (37)

1. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 196: 401-406.
2. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, et al. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9: 1144-1150.
3. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196: 389-399.
4. Joffre O, Gorsse N, Romagnoli P, Hudrisier D, van Meerwijk JP (2004) Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 103: 4216-4221.
5. Jones SC, Murphy Gr, Korngold R (2003) Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 9: 243-256.
6. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, et al. (2003) Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112: 1688-1696.
7. Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, et al. (2006) Effective expansion of alloantigen-specific Foxp3+CD25+CD4-+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A 103: 2758-2763.
8. Bushell A, Jones E, Gallimore A, Wood K (2005) The generation of CD25+CD4-+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J Immunol 174: 3290-3297.
9. Golshayan D, Jiang S, Tsang J, Garin MJ, Mottet C, et al. (2006) In vitro expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood.
10. Kohm AP, Carpentier PA, Anger HA, Miller SD (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreaactive immune responses and central nervous system inflammation during active experimental autommune encephalomyelitis. J Immunol 169: 4712-1716.
11. Mottet C, Uhlig HH, Powrie F (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170: 3939-3943.
12. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G et al (2001) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455-1465.
13. Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, et al. (2005) Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 175: 3053-3059.
14. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM (2004) CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.J Exp Med 199: 1467-1177.
15. Jin LP, Li DJ, Zhang JP, Wang MY, Zhu XY, et al. (2004) Adoptive transfer of paternal antigen-hyporesponsive T cells induces maternal tolerance to the allogeneic fetus in abortion-prone matings. J Immunol 173: 3612-3619.
16. Earle KE, Tang Q, Zhou X, Liu W, Zhu S, et al. (2005) In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation Clin Immunol 115: 3-9.
17. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104: 895-903.
18. Godfrey WR, Ge YG, Spoden DJ, Levine BL, June CH, et al. (2001) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104: 453-461.
19. Kreijveld E, Koenen HJ, Hilbrands LB, Joosten I (2006) Ex vivo expansion of human CD4(+)CD25(high) regulatory T cells from transplant recipients permits functional analysis ofsmall blood samples. J Immunol Methods.
20. Levings MK, Sangregorio R, Roncarolo MG (2001) Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193: 1295-1302.
21. Karakhanova S, Munder M, Schneider M, Bonyhadi M, Ho AD, et al. (2006) Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J Immunother 29: 336-349.
22. Roncarolo MG, Battaglia M (2007) Regulatory T-cell immunotherapy for tolerance to self anjgcris and alloantigens in humans. Nat Rev Immunol 7: 585-598.
23. Baecher-Allan C, Brown JA, Freeman GJ, Haller DA (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167: 1215-1253.
24. Fu S, Yopp AC, Mao X, Chen D, Zhang N, et al. (2004) CD4+CD25+CD62+T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 4: 65-78.
25. Liu, W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive funcuon of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
26. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
27. Koenen HJ, Fasse E, Joosten I (2005) CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells. J Immunol 174: 7573-7583.
28. Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, et al. (2002) Antigen-specific T cell suppression by human CDI+CD25+ regulatory T cells. Eur J Immunol 32: 1621-1630.
29. Coenen D, Koenen HJ, Emmer PM, van RE, Hilbrands LB, et al. (2007) Allogeneic stimulation of naturally occurring CDI(+)CD25(+) T cells induces strong regulatory capacity with increased donor-reactivity. Transpl Immunol 17: 237-242.
30. Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S (2001) Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 16: 1189-1201.
31. Hoffmann P, Boeld TJ, Eder R, Albrech J, Doser K, et al. (2006) Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12: 267-274.
32. Wichlan DG, Roddam PL, Eldridge P, Handgretinger R, Riberdy JM (2006) Efficient and reproducible large-scale isolation of human CD4(+) CD25(+) regulatory T cells with potent suppressor activity. J Immunol Methods.
33. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285: 412-415.
34. Koh LP, Rizzieri DA, Chao NJ (2007) Allogeneir: hematopoietic stem cell transplant using mismatched/haploidentical donors. Biol Blood Marrow Transplant 13: 1249-1267.
35. Afzali B, Lechler RI, Hernandez-Fuentes MP (2007) Allorecognition and the alloresponse: clinical implications. Tissue Antigens 69: 545-556.
36. Jiang S, Camara N, Lombardi G, Lechler RI (2003) Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 102: 2180-2186.
37. Koenen HJ, Fasse E, Joosten I (2003) IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J Immunol 171: 6431-6441.